August 1st, 2020 • 15 mins 34 secs • Download (14.3 MB) • Link with Timestamp
Dr John Heymach from the MD Anderson Cancer Center discusses the role of anti-angiogenic agents in NSCLC and the status of clinical research for and treatment of lung cancer at MD Anderson during the COVID-19 pandemic.